Top Markets
#1 Palladium Network Palladium Network +27.91%
#2 Ankr Network Ankr Network +23.31%
#3 Pons Pons +13.49%
#4 Status Status +13.44%
#5 BankrCoin BankrCoin +11.35%
#6 ICON ICON +11.33%
#7 Wiki Cat Wiki Cat +8.34%
#8 Siren Siren +8.02%
#9 WAX WAX +7.72%
#10 RedStone RedStone +7.43%
Coin of the day
Palladium Network Palladium Network
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Shukra Pharmaceuticals Limited Shukra Pharmaceuticals Limited

Shukra Pharmaceuticals Limited

SHUKRAPHAR
Peringkat dalam Saham #17790
Shukra Pharmaceuticals Limited is a prominent company engaged in the... Shukra Pharmaceuticals Limited is a prominent company engaged in the manufacturing and global distribution of pharmaceutical products. Their comprehensive product line addresses a broad spectrum of medical conditions, encompassing anti-infective medications (such as antibiotics, macrolides, quinolones, antivirals, antifungals, antimalarials, antiprotozoals, and anti-helminthics), central nervous system drugs (including sedatives, tranquilizers, antidepressants, and anti-manic agents), gastrointestinal treatments (like anti-emetics and anti-ulcer drugs), cardiovascular remedies (beta-blockers, diuretics), pain and inflammation management (analgesics, muscle relaxants, corticosteroids), anti-tuberculosis drugs, vitamin supplements, anti-allergy medications, and therapies for metabolic imbalances such as hyper- and hypoglycemia. The company was established on March 4, 1993, and its primary operations are directed from its headquarters in Ahmedabad, India.
Harga Saham
$0.51647906
Terakhir disinkronkan: 2026-09-02
Kapitalisasi Pasar
$226.16M
Perubahan (1 hari)
5.29%
Perubahan (1 tahun)
63.57%
Negara
IN
Perdagangan Shukra Pharmaceuticals Limited (SHUKRAPHAR)

Kategori

Healthcare
Laba untuk Shukra Pharmaceuticals Limited (SHUKRAPHAR)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari Shukra Pharmaceuticals Limited, laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Shukra Pharmaceuticals Limited dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$1.21B -
HK